A large genetic analysis has identified two new genes, ELL2 and ATRAID, that may be linked to a higher risk of developing gestational diabetes mellitus (GDM). The study combined data from genome-wide association studies (GWAS) in British, Finnish, and Chinese populations. Researchers found that variations in these genes were associated with GDM risk, and they also pinpointed biological pathways involved in insulin regulation and sugar metabolism.
This is an early-stage discovery. The findings are based on genetic associations, which do not prove that these genes cause diabetes. Instead, they point to potential targets for future research. No specific treatments or interventions are ready yet.
The study did not report on safety or side effects, as it was not a clinical trial. The main takeaway is that these genes may play a role in GDM, but more research is needed before any practical applications emerge.
For now, this research is most relevant to scientists studying the genetics of diabetes. Pregnant women or those at risk for GDM should continue to follow standard medical advice and screening recommendations.